Akari Therapeutics Plc ADR (AKTX) at a glance

Akari Therapeutics Plc ADR (AKTX) is a micro-cap Healthcare company. It trades at $9.83, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 45/100 overall. Its strongest dimension is Value (58/100) and its weakest is Momentum (23/100). It carries above-market volatility, so expect larger swings.

Price

$9.83

Market cap

$21.1M

P/E ratio

n/a

Dividend yield

None

Beta

1.33

52-week range

$3.02 to $49.60